Inspire Medical Systems (NYSE:INSP) Given Overweight Rating at KeyCorp
Inspire Medical Systems (NYSE:INSP – Get Free Report)‘s stock had its “overweight” rating restated by equities research analysts at KeyCorp in a research note issued to investors on Friday,Benzinga ...
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (8 Ratings)
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...
KeyBanc cuts Inspire Medical stock target to $234
KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...
Inspire Medical Systems (INSP) Gets a Buy from KeyBanc
In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...
Stifel cuts Inspire Medical stock target to $190 from $200
Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...
Does Medicare Cover a Sleep Study?
Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.
Inspire Medical Systems: Hold Rating Amidst Limited Revenue Upside and Slow Inspire V Launch
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...